Characterization of Polyethylene Glycol-Polyethyleneimine as a Vector for Alpha-Synuclein siRNA Delivery to PC12 Cells for Parkinson's Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of Polyethylene Glycol-Polyethyleneimine as a Vector for Alpha-Synuclein siRNA Delivery to PC12 Cells for Parkinson's Disease
Authors
Keywords
-
Journal
CNS Neuroscience & Therapeutics
Volume 20, Issue 1, Pages 76-85
Publisher
Wiley
Online
2013-11-27
DOI
10.1111/cns.12176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Attenuation of MPTP/MPP+ toxicity in vivo and in vitro by an 18-mer peptide derived from prosaposin
- (2013) H.L. Gao et al. NEUROSCIENCE
- Protective Effects of SKF-96365, a Non-Specific Inhibitor of SOCE, against MPP+-Induced Cytotoxicity in PC12 Cells: Potential Role of Homer1
- (2013) Tao Chen et al. PLoS One
- Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration
- (2012) Yanran Liang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract
- (2012) Ronit Shaltiel-Karyo et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- A review of nanocarriers for the delivery of small interfering RNA
- (2012) Prashant Kesharwani et al. BIOMATERIALS
- The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA
- (2012) Jinhuan Wei et al. BIOMATERIALS
- Investigation of the performance of PEG–PEI/ROCK-II-siRNA complexes for Alzheimer's disease in vitro
- (2012) Yunyun Liu et al. BRAIN RESEARCH
- A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
- (2012) TT Myöhänen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Nanovector delivery of siRNA for cancer therapy
- (2012) H Shen et al. CANCER GENE THERAPY
- Zonisamide Attenuates MPP(+)-Induced Oxidative Toxicity Through Modulation of Ca2+ Signaling and Caspase-3 Activity in Neuronal PC12 Cells
- (2012) Vedat Ali Yürekli et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
- (2012) Troy T. Rohn CNS & Neurological Disorders-Drug Targets
- Non-Viral Delivery of RNA Interference Targeting Cancer Cells in Cancer Gene Therapy
- (2012) Pin-I Huang et al. CURRENT GENE THERAPY
- Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo
- (2012) Yinting Chen et al. JOURNAL OF GASTROENTEROLOGY
- Novel disease-specific promoters for use in gene therapy for Parkinson's disease
- (2012) Erika Elgstrand Wettergren et al. NEUROSCIENCE LETTERS
- Role of Alpha-Synuclein Protein Levels in Mitochondrial Morphology and Cell Survival in Cell Lines
- (2012) Min Zhu et al. PLoS One
- α-Synuclein phosphorylation as a therapeutic target in Parkinson’s disease
- (2012) Steven P. Braithwaite et al. REVIEWS IN THE NEUROSCIENCES
- Design of Multifunctional Micelle for Tumor-Targeted Intracellular Drug Release and Fluorescent Imaging
- (2011) Weiwei Wang et al. ADVANCED MATERIALS
- An alpha-synuclein AAV gene silencing vector ameliorates a behavioral deficit in a rat model of Parkinson's disease, but displays toxicity in dopamine neurons
- (2011) Christina E. Khodr et al. BRAIN RESEARCH
- Alpha-synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease
- (2011) Arianna Bellucci et al. BRAIN RESEARCH
- Modulation of α-synuclein aggregation by dopamine in the presence of MPTP and its metabolite
- (2011) Prashant N. Jethva et al. FEBS Journal
- Non-viral gene therapy for neurological diseases, with an emphasis on targeted gene delivery
- (2011) Mary-Louise Rogers et al. JOURNAL OF CONTROLLED RELEASE
- Curcumin reduces α-synuclein induced cytotoxicity in Parkinson's disease cell model
- (2010) Min S Wang et al. BMC NEUROSCIENCE
- Gene therapy: a viable therapeutic strategy for Parkinson’s disease?
- (2010) Alexander L. Berry et al. JOURNAL OF NEUROLOGY
- Effects of MPP+ on the molecular pathways involved in cell cycle control in B65 neuroblastoma cells
- (2010) Javier G. Pizarro et al. PHARMACOLOGICAL RESEARCH
- α-Synuclein Suppression by Targeted Small Interfering RNA in the Primate Substantia Nigra
- (2010) Alison L. McCormack et al. PLoS One
- Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
- (2010) Ronit Shaltiel-Karyo et al. PLoS One
- α-Synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells
- (2009) Fengxia Wu et al. BRAIN RESEARCH
- Non-viral nanosystems for systemic siRNA delivery
- (2009) Stephanie David et al. PHARMACOLOGICAL RESEARCH
- Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells
- (2008) Young Su Han et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Polyhydroxylated fullerene derivative C60(OH)24prevents mitochondrial dysfunction and oxidative damage in an MPP+-induced cellular model of Parkinson's disease
- (2008) Xiaoqing Cai et al. JOURNAL OF NEUROSCIENCE RESEARCH
- In vivo silencing of alpha-synuclein using naked siRNA
- (2008) Jada Lewis et al. Molecular Neurodegeneration
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now